| __timestamp | Bausch Health Companies Inc. | Gilead Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 21102000000 |
| Thursday, January 1, 2015 | 7853800000 | 28633000000 |
| Friday, January 1, 2016 | 7063000000 | 26129000000 |
| Sunday, January 1, 2017 | 6176000000 | 21736000000 |
| Monday, January 1, 2018 | 6029000000 | 17274000000 |
| Tuesday, January 1, 2019 | 6251000000 | 17774000000 |
| Wednesday, January 1, 2020 | 5778000000 | 20117000000 |
| Friday, January 1, 2021 | 6040000000 | 20704000000 |
| Saturday, January 1, 2022 | 5760000000 | 21624000000 |
| Sunday, January 1, 2023 | 6198000000 | 20618000000 |
| Monday, January 1, 2024 | 78200000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, Gilead Sciences, Inc. and Bausch Health Companies Inc. have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, Gilead Sciences consistently outperformed Bausch Health in terms of gross profit, peaking in 2015 with a staggering 33% increase from the previous year. However, the subsequent years saw a decline, with a notable dip in 2018, marking a 40% decrease from its peak.
Conversely, Bausch Health's gross profit remained relatively stable, with a peak in 2015, followed by a gradual decline. Despite this, Bausch Health's gross profit in 2023 was only 21% lower than its 2015 peak, showcasing resilience amidst industry challenges. This analysis highlights the dynamic nature of the pharmaceutical sector and the strategic maneuvers companies must undertake to maintain profitability.
Key Insights on Gross Profit: AstraZeneca PLC vs Gilead Sciences, Inc.
Key Insights on Gross Profit: Novartis AG vs Bausch Health Companies Inc.
Gross Profit Trends Compared: Amgen Inc. vs Gilead Sciences, Inc.
Gilead Sciences, Inc. and Alnylam Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or Alkermes plc
Gross Profit Analysis: Comparing Gilead Sciences, Inc. and Corcept Therapeutics Incorporated
Zoetis Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Exelixis, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Perrigo Company plc vs Bausch Health Companies Inc.
Key Insights on Gross Profit: Bausch Health Companies Inc. vs Taro Pharmaceutical Industries Ltd.
Bausch Health Companies Inc. vs BioCryst Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown